According to GlobalData, the decision of the US regulator is likely to hurt Medtronic's sales, which currently occupies ...

The seriousness of this latest recall can be expected to have a noticeable effect on Medtronic’s laryngoscope sales.

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Medtronic plc (NYSE:MDT) is one of the largest medical device companies. It develops and manufactures ... On Aug. 20, the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), Prologis ...

During the quarter, broad U.S. equity markets rose amid moderating inflation, strong corporate earnings growth and weakening ...

Zacks Investment Research does not engage in investment banking, market making or asset management activities of any ...

Looking forward, we think Abbott will see better revenue growth than Medtronic in the next three years. While it will continue to see increased sales for its medical devices and nutritional ...

Joshua Brown of Ritholtz Wealth Management named 3M Co. as his final trade on CNBC's Halftime Report, while other experts shared picks like Visa and Medtronic.